KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo

KOBAYASHI PHARMACEUTICAL CO.,LTD.

Manufactures OTC pharma, personal care, and household goods for niche consumer markets.

4967 | T

Overview

Corporate Details

ISIN(s):
JP3301100008
LEI:
Country:
Japan
Address:
大阪市中央区道修町4丁目4番10号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kobayashi Pharmaceutical Co., Ltd. is a manufacturer and distributor of consumer products specializing in niche markets. The company's portfolio includes over-the-counter (OTC) pharmaceuticals, health and personal care items, and household goods. It is recognized for developing and marketing innovative products that address specific consumer needs and lifestyles, such as disposable body warmers, deodorizing air fresheners, and other personal wellness solutions. The company operates through various segments, including the manufacturing and sales of domestic household products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 08:30
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-08-08 08:30
Interim Report
半期報告書-第108期(2025/01/01-2025/12/31)
Japanese 226.4 KB
2025-03-31 08:27
Post-Annual General Meeting Information
臨時報告書
Japanese 25.4 KB
2025-03-28 07:33
Registration Form
確認書
Japanese 8.2 KB
2025-03-28 07:32
Governance Information
内部統制報告書-第107期(2024/01/01-2024/12/31)
Japanese 22.2 KB
2025-03-28 07:32
Annual Report
有価証券報告書-第107期(2024/01/01-2024/12/31)
Japanese 2.1 MB
2025-02-20 08:51
Post-Annual General Meeting Information
臨時報告書
Japanese 25.1 KB
2025-02-10 07:32
Legal Proceedings Report
訂正臨時報告書
Japanese 24.5 KB
2025-01-21 09:01
Board/Management Information
臨時報告書
Japanese 20.7 KB
2024-12-26 05:03
Major Shareholding Notification
臨時報告書
Japanese 20.5 KB
2024-11-08 07:41
Legal Proceedings Report
訂正臨時報告書
Japanese 24.1 KB
2024-08-09 08:00
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-08-09 08:00
Interim Report
半期報告書-第107期(2024/01/01-2024/12/31)
Japanese 240.4 KB
2024-08-08 08:30
Legal Proceedings Report
訂正臨時報告書
Japanese 24.0 KB
2024-07-23 08:29
Board/Management Information
臨時報告書
Japanese 20.9 KB

Automate Your Workflow. Get a real-time feed of all KOBAYASHI PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOBAYASHI PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOBAYASHI PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden
ECTIN B
Edesa Biotech, Inc. Logo
Develops treatments for inflammatory and immune diseases like Acute Respiratory Distress Syndrome.
United States of America
EDSA
Edgewise Therapeutics, Inc. Logo
Developing novel therapeutics for rare and serious muscle disorders.
United States of America
EWTX
Editas Medicine, Inc. Logo
Developing CRISPR-based genomic medicines to treat serious and rare genetic diseases.
United States of America
EDIT
Eevia Health Plc Logo
Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.
Finland
EEVIA
Egetis Therapeutics Logo
Develops and commercializes drugs for serious rare diseases with unmet medical needs.
Sweden
EGTX
EIKEN CHEMICAL CO.,LTD. Logo
Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.
Japan
4549
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan
4523
Elanco Animal Health Inc Logo
Develops medicines, vaccines, and services to treat and prevent disease in pets and farm animals.
United States of America
ELAN
Eledon Pharmaceuticals, Inc. Logo
Develops immunomodulatory therapies to prevent organ rejection in transplant patients.
United States of America
ELDN

Talk to a Data Expert

Have a question? We'll get back to you promptly.